Main > ONCOLOGY (**) > Leukemia>Myeloid>Chronic>Ph+ * > Treatment > Co.: CH. N. Brand Imatinib**



Co.: CH. N. Brand Imatinib**'s subsections
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Expiration Date: 2015. 01.04
Patent>Total USA No.: 3
Patent>UpDate: 2007. 01.23.
TradeMark (USA)
TradeMark (USA) Web-Site
UpDate: 2016. 07.06.

Co.: CH. N. Brand Imatinib**'s products
This section has no products